Top Markets
#1 CoW Protocol CoW Protocol +84.93%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Walrus Walrus +36.32%
#5 Humanity Humanity +16.84%
#6 Velvet Velvet +16.00%
#7 Cysic Cysic +15.83%
#8 The Black Bull The Black Bull +14.62%
#9 Tutorial Tutorial +14.59%
#10 Plume Plume +14.14%
Coin of the day
CoW Protocol CoW Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Kedudukan dalam Saham #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Harga Saham
$0.07600875
Disegerakkan terakhir: 2024-11-20
Modal Pasaran
$2.06M
Perubahan (1 hari)
-0.51%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Quantum Genomics S.A. (ALQGC)

Kategori

Healthcare
Margin Operasi untuk Quantum Genomics S.A. (ALQGC)
Margin Operasi pada August 2026 TTM: -14,728,350.00%
Menurut laporan kewangan dan harga saham terkini Quantum Genomics S.A., margin operasi semasa (TTM) ialah -14,728,350.00%. Pada akhir 2023, margin operasi syarikat ialah -15,847.92%.
Sejarah Margin Operasi untuk Quantum Genomics S.A. dari 2009 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Ubah
2026 (TTM) -14,728,350.00% 0.00%
2024 -14,728,350.00% 92,835.54%
2023 -15,847.92% 1,224.94%
2022 -1,196.12% 86.62%
2021 -640.95% -30.35%
2020 -920.28% 32.31%
2019 -695.54% -99.81%
2018 -368,912.10% 0.00%
2017 0.00% 0.00%
2016 0.00% -100.00%
2015 -2,990.22% 301.12%
2014 -745.46% -93.18%
2013 -10,934.16% 97.88%
2012 -5,525.72% -14.48%
2011 -6,461.44% -10.42%
2010 -7,212.81% -3.54%
2009 -7,477.55% 0.00%
Margin Operasi untuk syarikat serupa atau pesaing
Syarikat Margin Operasi Perbezaan Margin Operasi Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -100.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.00%
BE
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.